A Study of Intraperitoneal and Intravenous Paclitaxel Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells

NCT03718624 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer With Positive Exfoliative Cancer Cells

Interventions

DRUG: apatinib
DRUG: paclitaxel
DRUG: S-1

Sponsor

Hebei Medical University